Net sales/ Profits (Consolidated)

(Millions of yen)
Financial Year FY2017 FY2018 FY2019 FY2020 FY2021
Net sales 12,077 14,440 13,034 11,841 9,852
Operating income 182 962 454 ▲566 ▲859
Ordinary profit 214 1,032 499 ▲523 ▲685
Net income attributable to owners of the patent 198 692 357 ▲576 ▲1,271

Net sales

Operating income

Operating income

Ordinary profit

Ordinary profit

Net income attributable to owners of the patent

Net income

 

Profitability (Consolidated)

(%)
Financial Year FY2017 FY2018 FY2019 FY2020 FY2021
Operating income/Net sales 1.5 6.7 3.5 ▲4.8 ▲8.7
Ratio of ordinary profit to net sales 1.8 7.1 3.8 ▲4.4 ▲7.0
Net income/Net sales 1.6 4.8 2.7 ▲4.9 ▲12.9
Return on stockholders' equity (ROE) 1.4 4.7 2.4 ▲4.0 ▲9.6

Operating income/Net sales/Ratio of ordinary profit to net sales /Net income/Net sales

Operating income/Net sales/Ratio of ordinary profit to net sales /Net income/Net sales

Return on stockholders' equity (ROE)

Return on stockholders' equity (ROE)

 

Capital expenditures/ Depreciation/ R&D expenses  (Consolidated)

(Millions of yen)
Financial Year FY2017 FY2018 FY2019 FY2020 FY2021
Capital expenditures 254 500 877 1,136 235
Depreciation 777 758 787 824 798
R&D expenses 1,465 1,329 1,326 1,476 1,176

Capital expenditures/Depreciation/R&D expenses

Capital expenditures/Depreciation/R&D expenses

Update:2022/02/04